Form 4 for FLNA FILANA THERAPEUTICS, INC.
Accepted 2022-03-29 00:00:00 ET · period of report 2022-03-29 · accession 0001069530-22-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-29 | 2022-03-29 | FLNA | GUSSIN ROBERT Z | Dir | F - Tax | $39.98 | -4,024 | 8,410 | -32% | -$160.9K |
| DM | 2022-03-29 | 2022-03-29 | FLNA | GUSSIN ROBERT Z | Dir | M - OptEx | $21.53 | +7,470 | 12.4K | +150% | +$160.9K |
| DM | 2022-03-29 | 2022-03-29 | FLNA | GUSSIN ROBERT Z | Dir | M - OptEx | $21.53 | -7,470 | 0 | -100% | -$160.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-29 | F | D | 4,024 | $39.98 | 8,410 | D | — | — | (F1) Form 4 represents net exercise of stock options only. No shares of common stock were sold to third parties in this transaction. |
| 2 | Common | Common Stock | 2022-03-29 | M | A | 4,669 | $20.30 | 9,633 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-29 | M | A | 2,801 | $23.59 | 12,434 | D | — | — | |
| 4 | Derivative | Common Stock | 2022-03-29 | M | D | 2,801 | $23.59 | 0 | D | $23.59 · 2016-09-14 to 2022-09-14 | 2,801 Common Stock | |
| 5 | Derivative | Common Stock | 2022-03-29 | M | D | 4,669 | $20.30 | 0 | D | $20.30 · 2016-05-17 to 2022-05-17 | 4,669 Common Stock |